P256- innovative method of melanocyte and keratinocyte suspension in the treatment of stable vitiligo: a pilot study

vitiligo is a chronic skin disease affecting 1- 2 % of the population. the most common treatment options include local steroids, calcineurin inhibitors and phototherapy. surgical procedures including autologous melanocyte-keratinocyte suspension (mks) are presented to replace melanocytes in depigmented areas for stable segmental and focal. the purpose of this study was to evaluate the efficacy of an innovative method of mks in patients with stable recalcitrant vitiligo